Funding has been awarded to Dr McIlroy and Prof O’Reilly to develop a 3D bioprinting model to explore the impact of androgen excess on skeletal muscle energy metabolism in women with PCOS. New team member, Zahra Farahbakhsh, and Dr Leanne Cussen will be working with our industry partner, Inventia Life Sciences, to develop novel models of PCOS to improve our understanding of this complex disease and potentially help target patient treatment.